Tiba Biotech, a targeted recipient, had a $750,000 contract with BARDA set to end on October 30. They were developing an RNAi-based therapeutic for H1N1…
View More RFK Jr. Backs mRNA Research, But Not for Vaccines
Tag: Robert F. Kennedy Jr.